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Abstract
Diabetic retinopathy (DR) is a major cause of adult blindness. Retinal Mu¨ller cells maintain
water homeostasis and potassium concentration via inwardly rectifying Kir4.1 channels.
Accumulation of advanced glycation end products (AGEs) is a major pathologic event in
DR. While diabetes leads to a decrease in the Kir4.1 channels, it remains unknown whether
AGEs-linked to the basement membrane (BM) affect normal Kir4.1 channels. For this study,
we hypothesized that AGE-modification of laminin is detrimental to Kir4.1 channels, there-
fore, disrupting Mu¨ller cell function. The AGE-modified laminin-coated substrates were pre-
pared by incubating Petri-dishes with laminin and methylglyoxal for seven days. The rat
Mu¨ller cells (rMC-1) were propagated on AGE-modified laminin, and Kir4.1 expression and
function were evaluated. Quantification of AGEs using ELISA revealed a dose-dependent
increase in methylglyoxal-hydro-imidazolone adducts. The rMC-1 propagated on AGE-mod-
ified laminin demonstrated a decrease in Kir4.1 levels in immunofluorescence and western
blot studies and a decrease in the Kir4.1 channel function. Kir4.1 decrease on AGE-modified
laminin resulted in a disorganization of an actin cytoskeleton and disruption of α-dystrogly-
can-syntrophin-dystrophin complexes. Our studies suggest that AGE-modification of lami-
nin is detrimental to Kir4.1 channels. By studying the role of AGEs in Kir4.1 channels we
have identified a novel mechanism of Mu¨ller cell dysfunction and its subsequent involve-
ment in DR.
Introduction
Diabetic retinopathy (DR) is a leading cause of vision impairment and blindness in adults that
affects roughly seven million individuals in the United States [1]. The combination of high
metabolic demand and nominal vascular supply limits the retina’s ability to assimilate to the
metabolic stress of diabetes. The retina is the most vulnerable tissue affected by diabetic milieu
due to its intricate network of vascular and neural cells that require high oxygen demand with
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limited vascularity [2]. Diabetes immensely enhances the accumulation of advanced glycation
end products (AGEs) through the glycation of proteins thereby disrupting molecular confor-
mation, altering enzymatic activity, and interfering with receptor function. AGEs create cross-
links with proteins, lipids and nucleic acids accumulating first extracellularly through the base-
ment membrane (BM), and then intracellularly leading to the development of diabetic compli-
cations [3, 4]. The accumulation and increased formation of AGEs in retinal neurons, the
vasculature, and the BM of the retina play a critical role in the development of DR [5–7]. BM-
modification by AGEs is detrimental to integrin signaling resulting in dysfunction of the reti-
nal neurovascular unit leading to diabetic complications such as DR [8].
Mu¨ller cells are an integral component of the retinal cellular environment [9]. Mu¨ller glia
span across the entire thickness of the retina to maintain the stability of the retinal extracellular
environment by regulating potassium levels, uptaking neurotransmitters, storing glycogen,
creating an electrical insulation of receptors and other neurons, and acting as mechanical sup-
port between retinal neurons, retinal blood vessels, and the vitreous humor [10]. Mu¨ller cells
regulate K+ balance via inwardly rectifying Kir4.1 channels. Notably, the polarized pattern of
Kir4.1 exhibits a strong decrease in perivascular regions in diabetic retinas expressing Mu¨ller
cell markers [11, 12]. Our studies demonstrate that Mu¨ller cells exhibit a functional clock with
a diurnal rhythm of Kir4.1 and diabetes disturbs the natural circadian rhythm of Kir4.1 [13].
AGEs are known to induce Mu¨ller cell dysfunction [14], but it remains unknown how AGE-
modification of BM affects Kir4.1 channels in diabetes.
In the present study, we examine the effects of laminin, a critical BM component that con-
tributes to cell attachment, differentiation, migration, and adhesion to promote cell survival.
Previous studies suggest that laminin is required for normal Kir4.1 expression in Mu¨ller cells
[15]. However, it is unknown whether AGE-modification of laminin is detrimental to Kir4.1
expression. We hypothesized that AGE-modification of the laminin leads to a decrease in
Kir4.1 channels, thereby resulting in Mu¨ller cell dysfunction. Methylglyoxal (MGO) is a dicar-
bonyl compound generated by cell metabolism, glucose oxidation and lipid peroxidation [16,
17]. This highly reactive compound undergoes a rapid modification in hyperglycemic condi-
tions such as diabetes leading to the formation of irreversible AGEs [17, 18]. We used MGO as
an AGE-intermediate to prepare AGEs in vitro. The laminin-coated Petri-dishes were incu-
bated with MGO for seven days and then quantified for AGEs. Additionally, we tested Kir4.1
expression and function in rat Mu¨ller cells (rMC-1) propagated on AGE-modified laminin.
Our studies demonstrate that AGE-modification of laminin downregulates Kir4.1 expression




The rat Mu¨ller cells (rMC-1; #RRID: CVCL_8140) were obtained as a gift from Dr. Vijay
Sarthy, Northwestern University and Dr. Timothy S. Kern, Case Western Reserve University,
Cleveland, OH. The rMC-1 cells were cultured in T-75 flasks in Dulbecco Modified Eagle
Medium (DMEM) supplemented with 10% fetal bovine serum (FBS) and antibiotic-antimyco-
tic (Gibco-Life Technologies, Thermo Fishers, Grand Island, NY). The rMC-1 cells were
authenticated using rat short tandem repeat (STR) analysis, interspecies contamination test
and mycoplasma at IDEXX Bioresearch, Columbia, MO. The rMC-1 cells were found to be
negative for mycoplasma and the samples were confirmed to be of rat origin without any
mammalian interspecies contamination. In addition, the rMC-1 cells demonstrated a promi-
nent band of glutamine synthase-1 (GS-1) in western blot studies (S1 Fig)
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Preparation of AGE-modified laminin
AGE-modified laminin was prepared by coating Petri-dishes with laminin (20 μg/ml; Sigma-
Aldrich, St. Lois, MO) for 2 hours at 37˚C followed by incubating Methylglyoxal (MGO) (10,
100 & 1000 μM; Sigma-Aldrich, St. Lois, MO) for 7 days at 37˚C. The AGE substrates were
washed with PBS to remove any excess methylglyoxal and unbound adducts.
Quantification of AGE adducts
AGE-modified laminin was prepared in microcentrifuge tubes similar to AGE-modified sub-
strates. The glycated and control proteins were dialyzed against 30 mmol/l ammonium for-
mate, pH 7.8 and 4˚C. AGEs were quantified via detection of methylglyoxal-hydro-
imidazolone (MG-H1) adducts using Methylglyoxal Competitive ELISA. (Cell Biolabs, Inc.,
San Diego, CA)
Western blotting
The rMC-1 cells were pelleted and lysed in RIPA buffer (Sigma-Aldrich, St. Louis, MO). Pro-
tein Concentration was estimated using BCA assay (Pierce, Thermo Scientific, Rockford, IL),
and equal amounts of proteins (30 μg) were loaded and separated on 4–12% Bis-Tris gels
(Novex, Life Technologies, Carlsbad, CA). Proteins were transferred to a PVDF membrane
(Life Technologies), which was blocked with 5% milk or BSA as per the antibody requirement.
The following antibodies were used for probing: Kir4.1 goat-rabbit (1:2000; Alomone Labs,
Jerusalem, Israel), glutamine synthase -1, (GS-1; 1:500, EMD-Millipore, Burlington, MA),
TWIK (1:200; Alomone labs), α-Tubulin goat-mouse (1:5000; Sigma-Aldrich, St. Louis, MO)
and β-actin (1:5000: Sigma-Aldrich) antibodies. The PVDF membranes were incubated with
the aforementioned primary antibodies overnight at +4˚C. The following set of antibodies
were used as a secondary loading control: HRP goat-mouse for α-Tubulin (1:100; Sigma-
Aldrich), and HRP goat-rabbit for Kir4.1 (1:2000; Sigma-Aldrich). The secondary antibody
incubations were performed for two hours at room temperature. The bands were visualized
using ECL2 western blotting substrate (Pierce, Thermo Scientific, Rockford, IL) on an XRS gel
documentation system with Quantity One software (Bio-Rad, CA).
Immunofluorescence of Kir4.1
rMC-1 cells were fixed in 4% paraformaldehyde for 20 minutes followed by 5 minutes of
D-PBS in 0.05% Tween solution. The cells were blocked for 2 hours in 2% Goat Serum fol-
lowed by incubation with primary antibody Kir4.1 (1:200; Alomone Labs) overnight at +4˚C.
The primary antibody was removed by three total washes with D-PBS in 0.05% Tween. The
secondary antibody staining was performed using fluorescent-conjugated Alexa fluor 488
(1:500; Invitrogen-Molecular Probes, ThermoFischer, Rockford, IL) incubated for two hours
at room temperature. Finally, the slides were mounted in a Slow fade DAPI mounting media
and imaged via a confocal microscope (Zeiss LSM 510 META; Carl Zeiss MicroImaging
GmbH, Jena, Germany) and analyzed through Zen11 software (Zeiss, Thornwood, NY).
Electrophysiological recordings
The constructs pcDNA3.1-Kir4.1 (9.5 μg) and pMax-EGFP (0.5 μg) were transiently co-trans-
fected into rMC-1 cells using the Lipofectamine 2000 (Invitrogen-Life Technologies). Cells
were seeded on glass coverslips on control or AGE-matrix and incubated at 37˚C for 24 hrs
prior to patch-clamp recording.
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Whole-cell voltage-clamp recordings were performed at room temperature (~21˚C) using
an EPC-10 amplifier and the Pulse program (HEKA Electronics). Fire-polished electrodes
(1.0–2.0 MO) were fabricated from 1.7 mm capillary glass using a P-97 puller (Sutter Instru-
ments). The pipette solution contained (in mM): 140 KCl, 1.1 EGTA, 10 NaCl and 10 HEPES,
pH 7.3. The bathing solution was (in mM): 140 NaCl, 3 KCl, 1 mm MgCl2, 1 CaCl2, and 10
HEPES, pH 7.3 (adjusted with NaOH). The offset potential was zeroed before contacting the
cell. After establishing the whole-cell recording configuration, the resting potential was held at
-60 mV for 5 min to allow adequate equilibration between the micropipette solution and the
cell interior. Membrane currents were usually filtered at 5 kHz and sampled at 20 kHz. Voltage
errors were minimized using 70%-80% series resistance compensation.
Staining for actin cytoskeleton in rMC-1 cells
rMC-1 cells were propagated on 8-well chamber slide coated with AGE-modified laminin for
24 hours and fixed using 4% paraformaldehyde for 20 minutes. Filamentous actin (F-actin)
were stained using Phalloidin antibodies (Invitrogen-Molecular Probes, ThermoFischer,
Rockford, IL) to visualize the f-actin. The confocal images of f-actin were imaged via a confocal
microscope (Zeiss LSM 510 META; Carl Zeiss MicroImaging GmbH, Jena, Germany) and
analyzed through Zen11 software (Zeiss, Thornwood, NY).
Quantification of α-Dystroglycan complexes in rMC-1
rMC-1 cells were propagated on 8-well chamber slide coated with AGE-modified laminin for
24 hours. The primary antibody was directly added to media and incubated for thirty minutes
at +4˚C using anti-α-Dystroglycan (1:100; EMD Millipore, Darmstadt, Germany) followed by
secondary staining using fluorescently conjugated antibodies Alexa fluor 488 (1:400) for one
hour at room temperature. The slide was washed in PBS and mounted in SlowFade gold with
DAPI mounting media and imaged using a confocal microscope (Zeiss LSM 510 META; Carl
Zeiss MicroImaging GmbH, Jena, Germany) and analyzed through Zen11 software (Zeiss,
Thornwood, NY). Quantification of α-Dystroglycan complexes were performed by counting
hyperfluorescent spots using image-analysis software (ImageJ; National Institutes of Health,
Bethesda, MD; available by ftp @ zippy.nimh.nih.gov/ or at http://rsb.info.nih.gov/nih-image;
developed by Wayne Rasband, National Institutes of Health, Bethesda, MD).
Syntrophin and dystrophin colocalization analysis
rMC-1 cells were propagated on 8-well chamber slides coated with AGE-modified laminin
overnight at 37˚C. All treatment groups were stained simultaneously. The cells were blocked
for 2 hours in 2% Goat Serum and then incubated with both anti-syntrophin (1:200, Abcam,
Cambridge, MA) and anti-dystrophin (1:200 ab15277, Abcam) primary antibodies overnight
at +4˚C. The primary antibodies were removed by three total washes with D-PBS in 5%
Tween. The secondary stain was added by incubating fluorescent-conjugated antibodies Alexa
488 (1:500) and Alexa 594 (1:500) for syntrophin and dystrophin, respectively, for two hours at
room temperature. The cells were mounted in a Slow fade DAPI mounting media and imaged
via a confocal microscope (Zeiss LSM 510 META) and analyzed through Zen11 software
(Zeiss, Thornwood, NY). The confocal images were captured by keeping confocal settings con-
stant across the treatment groups. Determination of the colocalization coefficients was per-
formed using the image-analysis software, Icy (Institut Pasteur, Paris, France). First, the
Thresholder plugin was used to automatically create an intensity threshold for each image.
Then, the colocalization coefficients were calculated using the colocalization studio plugin.
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Statistics
All data were expressed as mean ± SEM. Statistical analysis was performed using a Graph Pad-
Prizm 6 (GraphPad Software, La Jolla, CA) software. The normality of data was tested using
either a D’Agostino & Pearson normality test or Shapiro-Wilk normality test prior to under-
taking parametric testing of statistical analysis. The statistical significance was evaluated using
Student’s t-test or a One-Way ANOVA followed by a Tukey’s post- hoc test, unless and other-
wise specified. Each experiment was repeated at least n = 3 times unless and otherwise speci-
fied. The data were considered statistically significant when the p-value was less than 0.05.
Results
AGEs show a concentration-dependent increase following methylglyoxal
treatment
AGEs were quantified as methylglyoxal-hydro-imidazolone (MG-H1) adducts using competi-
tive ELISA. MG-H1 is the AGE formed from the methylglyoxal intermediate. We observed a
concentration-dependent increase in MG-H1 adducts after treatment with methylglyoxal (10–
1000 μM). The linear regression analysis exhibited a concentration-dependent increase in
MG-H1 adducts (p<0.05). The 100 μM (380.2 ± 30.3) and 1000 μM (1680 ± 23.6) groups dif-
fered significantly as compared to control group, however, for 10 μM (46.1 ± 6.5), this differ-
ence was statistically insignificant (Fig 1).
AGE-modification of laminin leads to a decrease in Kir4.1 protein
expression
To study the effect of AGE-modified laminin on Kir4.1 expression, the rMC-1 cells were prop-
agated on varying concentrations of AGE-modified laminin. The AGE-modification of lami-
nin did not affect the viability of rMC-1 cells (S2 Fig). Western Blot and immunofluorescence
studies were performed to determine Kir4.1 protein expression. Immunofluorescence imaging
of rMC-1 cells stained Kir4.1 antibodies revealed a significant decrease in the Kir4.1 expression
on AGE-modified substrates as compared to untreated laminin (Fig 2A); thereby suggesting
that AGE-modification of the BM affects Kir4.1 expression. Further, the western blot demon-
strated a negative correlation between Kir4.1 protein expression and the concentration of
AGE-modified laminin (Fig 2B). In order to quantify the western blot data, the integrated opti-
cal density (IOD) was determined for respective Kir4.1 and α-tubulin bands. The IOD of treat-
ment groups was determined by normalizing the data to an untreated group. We observed a
1.6-fold decrease (0.63 ± 0.09; p<0.05) in Kir4.1 expression in cells propagated on 10 μM
AGE-modified laminin. A 1.9-fold decrease (0.52 ± 0.06; p<0.01) was observed in cells propa-
gated on 100 μM and for a 1000 μM group this decrease was about 2-fold (0.48 ± 0.09 p<0.01).
AGE-modification of laminin causes a decrease in Kir4.1 function
Next, we tested whether the decrease in Kir4.1 expression reflects a functional change in the
K+ channel, we performed the whole-cell recordings for Kir4.1 currents. As the rMC-1 cells
did not evoke Kir4.1 currents by itself, we first transfected rMC-1 cells transiently with
pcDNA3.1-Kir4.1 and pMax-EGFP. The whole cell Kir4.1 currents were determined on rMC-
1 cells seeded on control and 10 μM AGE-modified laminin. We observed a decrease in Kir4.1
currents on AGE-modified laminin (Fig 3A) and there was a significant decrease (contol =
-4.25 ± 1.33; 10 μM = -0.60 ± 0.19; p<0.05) in mean amplitude on AGE-modified laminin (Fig
3B).
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AGE-modification of laminin results in disorganization actin cytoskeleton
and a decrease of α-Dystroglycan complexes
We used immunofluorescent imaging to determine how modification of the laminin affects the
distribution of the actin cytoskeleton and α-Dystroglycan complexes in correspondence with the
decrease in Kir4.1 expression with an increase in treatment. To determine disorganization of the
actin cytoskeleton, rMC-1 cells were propagated on AGE-modified laminin and stained with phal-
loidin antibodies. The treatment of rMC-1 cells on AGE-modified laminin resulted in disorganiza-
tion of actin skeleton and the actin was mostly observed in clumps in the cytoplasm of rMC-1 cells
(Fig 4). These results suggest that BM modification is detrimental to the integrity of the cell.
Quantification of α-Dystroglycan complexes were determined through immunofluorescent
imaging as previously described [19] to provide further information regarding the possible
biological mechanism of decrease in Kir4.1 due to AGE-modified laminin. As shown in Fig
5A,α–Dystroglycan complexes decreased significantly with increased AGE-modification.
Quantification of the α-Dystroglycan complexes (Fig 5B) revealed a 5.5-fold decrease in com-
plexes between untreated cells (21.5 ± 3.3) and cells plated on AGE-modified laminin 1000μM
(3.9 ± 0.6; p<0.05), a 4.3-fold decrease in complexes between untreated and cells plated on
AGE-modified laminin 100 μM (5 ± 0.5; p<0.05), and a 2.6-fold decrease in complexes
between untreated and cells plated on AGE-modified laminin 10 μM (8.2 ± 1.2; p<0.05). The
significant decrease in α-Dystroglycan complexes suggest a strong link between the distribu-
tion of these complexes and the expression of Kir4.1.
AGE-modification of laminin decreases co-localization of syntrophin and
dystrophin on AGE-modified laminin
Previous studies demonstrate that Mu¨ller cell binding to laminin anchors α-Dystroglycan
complexes followed by redistribution of protein complexes such as syntrophin and dystrophin
Fig 1. Quantification of AGEs using ELISA. Laminin was incubated with methylglyoxal and AGEs were quantified as
methylglyoxal-hydro-imidazolone (MG-H1) adducts using competitive ELISA. Bar chart showing a concentration-
dependent increase in MG-H1 adducts after treatment with methylglyoxal, n = 7.
https://doi.org/10.1371/journal.pone.0193280.g001
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[19]. After observing a decrease in α-Dystroglycan, we hypothesized that AGE-modification
of laminin will further lead to a decrease/distribution of downstream syntrophin-dystrophin
protein expression. To test this hypothesis, we co-stained the rMC-1 cells propagated on
AGE-modified laminin with syntrophin and dystrophin antibodies. We observed that with
an increase in AGE concentration the cytoplasmic distribution of syntrophin clustered
towards cell membrane. There was an overall decrease in the dystrophin levels on AGE-modi-
fied laminin (Fig 6A). We further quantified the co-localization of syntrophin and dystrophin
using Mander’s colocalization coefficient, our studies revealed that there was a significant
decrease in syntrophin coefficient at 100 μM (0.70 ± 0.03; p<0.001), and 1000 μM (0.76 ± 0.03;
p<0.01) concentration (Fig 6B), however, this decrease was insignificant for 10 μM of AGE-
modified laminin (0.87 ± 0.02) when compared to a control group (0.91± 0.01). The dys-
trophin coefficient was decreased significantly at all the concentrations of methylglyoxal
Fig 2. Decrease in Kir4.1 protein expression in rMC-1 cells propagated on AGE-modified laminin. rMC-1 cells
were plated on AGE-modified laminin and the Kir4.1 expression was determined using immunofluorescence and
western blot. (A) rMC-1 cells were stained with Kir4.1 antibodies followed by secondary staining with Alexa 488. The
immunofluorescence staining of Kir4.1 revealed a profound decrease in the Kir4.1 expression on AGE-modified
substrates as compared to untreated laminin. (B) Representative western blot showing a decrease in Kir4.1 expression.
(C) Bar chart showing a quantification of the western blots, n = 4.
https://doi.org/10.1371/journal.pone.0193280.g002
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(10 μM = 0.75 ± 0.02; 100 μM = 0.69 ±0.03; 1000 μM = 0.68 ± 0.02; p<0.001; Fig 6C) when
compared to a control group (0.90 ± 0.01).
Discussion
Mu¨ller cells play an important role in the retina by maintaining the architecture and high
physiological demand. In diabetes, the Mu¨ller cells are dysfunctional due to an increased syn-
thesis of glutamate, increase in glial fibrillary acidic protein, and Mu¨ller cell swelling due to
Fig 3. AGE-modification of laminin leads to a decrease in Kir4.1 function. (A) Representative current traces of
Kir4.1 currents under control and AGE-modified matrix (10 μM). Currents were elicited by applying 50-ms
depolarizing potentials ranging from -140 mV to +30 mV from a holding potential of -60 mV (10-mV increment).
Dash line indicates zero-current level. (B) Mean amplitude of the inward potassium currents elicited at -140 mV
(control, n = 7; 10 μM, n = 9). p< 0.05.
https://doi.org/10.1371/journal.pone.0193280.g003
Fig 4. AGE-modification of laminin results in disorganization actin cytoskeleton in rMC-1 cells. rMC-1 cells were
propagated on AGE-modified laminin and stained for the phalloidin antibodies. The untreated cells exhibited
continuous trans cytoplasmic actin filaments (white arrow). The treatment of rMC-1 cells on AGE-modified laminin
resulted in disorganization of actin skeleton and the actin was mostly observed in clumps in the cytoplasm (yellow
arrow), n = 3.
https://doi.org/10.1371/journal.pone.0193280.g004
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downregulation of the Kir4.1 channels. Mu¨ller cells regulate K+ balance via inwardly rectifying
Kir4.1 channels. Notably, the polarized pattern of Kir4.1 exhibits a strong reduction in perivas-
cular regions in diabetic retinas [11, 12]. A variety of mechanisms are associated with
decreased Kir4.1 expression in diabetes, such an involvement of arachidonic acid pathway
[11], increase in VEGF, IL-1β, and ionized calcium binding protein. In addition, AGE accu-
mulation in vascular and neural cells of the retina is a major pathological event in the develop-
ment of DR [6]. The present study identified a critical role of matrix immobilized AGEs on
Mu¨ller cell function by demonstrating that AGE-modified laminin affects negatively to Kir4.1
function. Further, we found that the defect in Kir4.1 function was attributed to disruption and
disorganization of an actin-dystroglycan-syntrophin-dystrophin complex. Together, the pres-
ent study demonstrates a novel mechanism of Kir4.1 decease in diabetes by ascertaining the
role of basement membrane signaling.
Matrix immobilized AGEs are shown to be detrimental to the retina. Previous studies sug-
gest that bovine retinal pericytes on AGE-modified fibronectin undergo apoptosis and exhibit
an increased level of reactive oxygen species [20]. We previously reported that AGE-modifica-
tion of fibronectin affects the reparative ability of endothelial precursor cells due to dysfunc-
tional integrin-mediated signaling [21]. When the AGE-modified fibronectin was replenished
with key peptides known to help with cellular attachment, we observed a reversal of basic cellu-
lar functions such as cell attachment, spreading and migration [21]. A similar effect of AGE-
Fig 5. Decrease in α-Dystroglycan complexes in rMC-1 cells propagated on AGE-modified laminin. rMC-1 cells
were stained with α-dystroglycan antibodies followed by secondary staining using fluorescently conjugated antibodies.
(A) Representative photomicrographs showing a decrease in α-dystroglycan expression in rMC-1 cells treated with
AGE-modified laminin. (B) Quantification of α-dystroglycan complexes revealed a decrease in dystroglycan formation
in rMC-1 cells propagated on AGE-modified laminin, n = 3.
https://doi.org/10.1371/journal.pone.0193280.g005
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modified fibronectin was observed on retinal capillary endothelium and their reparative
potential [22]. Laminin is critical to Kir4.1 signal in the Mu¨ller cells, Ishi et al. previously
reported that replenishment of Mu¨ller cells with laminin helped to restore Kir4.1 expression
which otherwise was lost in tissue culture [15]. Our study further builds on a critical role of
basement membrane-mediated signaling by identifying an important role of laminin on
Kir4.1 function. Also, our studies further suggest that AGE-modification of laminin results in
downregulation TWIK channels (S3 Fig) and speculate that AGE modification of basement
membrane may be detrimental to other potassium channels in the retina.
Fig 6. Decrease in colocalization of syntrophin and dystrophin on AGE-modified laminin. rMC-1 cells were
propagated on AGE-modified laminin followed by staining with syntrophin and dystrophin antibodies, the images
were taken using confocal microscopy. (A) Representative photomicrographs showing a decrease in the staining of
dystrophin and clustering of syntrophin near cell membrane on AGE-modified laminin. Bar chart showing a Mander’s
colocalization coefficient for (B) Syntrophin and (C) Dystrophin, n = 3.
https://doi.org/10.1371/journal.pone.0193280.g006
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MGO with arginine forms a major adduct, methylglyoxal-derived hydroimidazolone
(MG-H), which is known to be increased in lens [23] and retina [24]. We observed a signifi-
cant increase in AGE adduct (MG-H1) on laminin with increased concentrations of the
methylglyoxal. For this study, we used methylglyoxal concentrations in the range of 10–
1000 μM which resulted in the formation of MG-H1 adducts in the range of (45–1700 pmol/
mg of protein). The MG-H1 adducts measured in our study are line with the previous studies
which report MG-H1 levels in the human lens as 4609 pmol/mg of protein [23].
One of the limitations of our study is the use of immortalized cell line, rMC-1 cells in our
studies. These cell lines are known to express markers similar to primary culture Mu¨ller cells
such as CRALBP, GS-1 [25] and have been used in several studies over past years [26–29]. It is
noteworthy, that AGE inhibition in vivo using pyridoxamine was protective against diabetes-
induced Kir4.1 decrease [14]. We believe that our study further enabled understanding of such
protective mechanism using robust cell system, such as rMC-1 cells.
Diabetic conditions have been shown to alter K+ channels in retinal glial cells causing a
decrease of the K+ conductance in Mu¨ller cells [11]. The decrease in Kir4.1 channels, normally
releasing excess K+ in the process of spatial K+ buffering, causes a disturbance of the retinal K+
homeostasis as seen in diabetes-induced dysfunction. We found that intracellular K+ absor-
bance of AGE-modified rMC-1 cells not only proves detrimental to the distribution of Kir4.1,
but it also causes a decrease in Kir4.1 function. Our electrophysiological studies support the
assertion that there is a decrease in Kir4.1 function on AGE-modified laminin, however, prior
Kir4.1-cDNA transfection was necessary to elicit Kir4.1 currents. While acknowledging this
limitation we provide an indirect evidence of a decrease in Kir4.1 function and implicate the
possibility of an overall decrease in K+ buffering on AGE-modified laminin.
α-dystroglycan is expressed by the Mu¨ller cell endfeet where it functions as a laminin receptor
and helps in mediating Mu¨ller cell interactions with that of the extracellular matrix [19]. Extracel-
lularly, laminin connects to α-dystroglycan which connect to β-dystroglycan to connect intracel-
lularly to dystrophin which binds to the actin cytoskeleton and syntrophin. We found that AGE-
modification of laminin resulted in disorganization of the actin cytoskeleton in rMC-1 cells. Fur-
thermore, immunofluorescent imaging demonstrated a profound decrease in α—Dystroglycan
complexes and decrease in colocalizaiton of syntrophin-dystrophin complex as AGE-modification
of laminin increased, emphasizing critical role of laminin in Kir4.1 expression in Mu¨ller cells.
In conclusion, our study has identified a novel mechanism of Mu¨ller cell dysfunction
observed in diabetes by studying the critical role of AGE-modified laminin. In future, pharma-
cological strategies targeted at correcting matrix mobilized AGEs would be helpful to correct
Mu¨ller cell dysfunction observed in DR.
Supporting information
S1 Fig. GS-1 staining of rMC-1 cells. A representative western blot image showing a promi-
nent band of glutamine synthase 1 (GS-1) in rMC-1 cells.
(TIF)
S2 Fig. Cell viability on AGE-modified laminin. The Alamar blue was added after 24 hrs to
rMC-1 cells plated on AGE-modified laminin. Bar chart showing AGE-modification of lami-
nin did not affect viability of rMC-1 cells when compared to control, n = 3.
(TIF)
S3 Fig. TWIK expression on AGE-modified laminin. Western blot showing a decrease in the
levels of TWIK in rMC-1cells treated on AGE-modified laminin.
(TIF)
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